Nicholson v. Eli Lilly & Co. (In re Darvocet, Darvon & Propoxyphene Prods. Liab. Litig.)

Danny C. Reeves

In accordance with the Court's Order Granting Defendant Xanodyne Pharmaceuticals, Inc.'s Motion to Dismiss and Motion for Judgment on the Pleadings in 14 Cases [MDL Record No. 1791], Order dismissing remaining Generic Defendants [MDL Record No. 1973], Memorandum Opinion and Order Regarding AAIPharma, LLC's AAIPharma, Inc.'s AAIPharma Development Services, Inc.'s, and NeoSan Pharmaceutical, Inc.'s Motion to Dismiss [MDL Record No. 2150], and Memorandum Opinion and Order Granting Defendant Eli Lilly and Company's Third Master Motion for Judgment on the Pleadings in Twelve Cases [MDL Record No. 2184], and pursuant to Rule 58 of the Federal Rules of Civil Procedure, it is hereby

ORDERED and ADJUDGED as follows:

(1) Judgment is entered in favor of Eli Lilly and Company; aaiPharma, Inc.; aaiPharma LLC; AAI Development Services, Inc.; NeoSan Pharmaceuticals Inc.; Xanodyne Pharmaceuticals, Inc.; Qualitest Pharmaceuticals, Inc.; Vintage Pharmaceuticals, Inc.; Propst
Distribution, Inc.; Brenn Distribution, Inc.; Brenn Manufacturing, Inc.; Vintage Pharmaceuticals, LLC; Generics International (US), Inc.; Generics Bidco I, LLC; Generics Bidco II, LLC; Generics International (US PARENT), Inc.; Endo Pharmaceuticals, Inc.; Endo Pharmaceuticals Holdings, Inc.; Covidien PLC; Covidien Inc.; Mallinckrodt, Inc.; Teva Biopharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals, Inc.; Mylan, Inc.; and Watson Pharmaceuticals, Inc. with respect to all claims asserted herein.
(2) This action is DISMISSED and STRICKEN from the Court's docket.
(3) This is a FINAL and APPEALABLE Judgment and there is no just cause for delay.

Signed By:

Danny
C. Reeves

United States District Judge